Match Document Document Title
US20110262540 Solid Pharmaceutical Composition Comprising Exemestane  
A solid pharmaceutical composition of exemestane, in particular for oral use and treatment of cancer, comprises micronized exemestane and anti-oxidant in a film-coated tablet.
US20060063938 Compounds to treat hiv infection and aids  
The present invention relates to compounds of formula I: useful HIV infection, AIDS, and other similar diseases. These compounds include inhibitors of the retroviral integrase enzyme that are...
US20100160657 SYNTHETIC MIMICS OF MAMMALIAN CELL SURFACE RECEPTORS: METHOD AND COMPOSITIONS  
The present invention relates to new synthetic receptors. More particularly, the present invention relates to methods for synthesizing preferred membrane-binding elements, preferably...
US20070225512 SYNTHESIS OF A MIXTURE OF SULFATED ESTROGENS USING A SULFUR TRIOXIDE COMPLEX  
A process of producing a stable composition comprising a mixture of sulfated estrogens. The mixture of sulfated estrogens may comprise sulfated alkali metal salts of Δ8,9-dehydroestrone, estrone,...
US20070249567 2-Methylene-19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Its Uses  
This invention discloses 2-methylene-19,26,27-trinor-(20S)-vitamin D analogs, and specifically 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and pharmaceutical uses therefor. This...
US20150005267 ANXIOLYTIC MARCGRAVIACEAE COMPOSITIONS CONTAINING BETULINIC ACID, BETULINIC ACID DERIVATIVES, AND METHODS  
Pharmaceutical compositions for preventing or treating anxiety, comprising betulinic acid or derivatives thereof are provided. Methods for preventing or treating anxiety with betulinic acid or...
US20120309713 N-Cyclopropyl-(20R)-2-Methylene-19,26,27-Trinor-25-Aza-Vitamin D Analogs and Their Uses  
This invention discloses N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitam in D analogs, and specifically N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-1α-hy droxyvitamin D3...
US20130203717 Process for Particle Processing of Active Pharmaceutical Ingredients  
A process for reducing the particle size of an active pharmaceutical ingredient (API) while maintaining its polymorphic form, comprises the step of processing the active pharmaceutical ingredient...
US20120127633 METAL ELECTROLYTIC CAPACITOR, AND ABSORBENT AND LEAKAGE PREVENTION MATERIAL FOR METAL ELECTROLYTIC CAPACITOR  
A metal electrolytic capacitor capable of quickly absorbing and immobilizing a belching vapor of a driving electrolyte and widely reducing leakage when an explosion-proof valve operates. An...
US20060047108 Synthesis of idarubicin aglycone  
The present invention provides a new method of producing high quality idarubicin aglycone from 4-protected demethoxydaunomycinones such as 4-demethoxydaunomycinone-4-triflate.
US20100179111 SIGMA-1 RECEPTOR LIGANDS AND METHODS OF USE  
The invention provides compounds of formula I and compositions thereof. The invention further provides methods of using the compounds and compositions. The compounds of the invention can provide...
US20080206658 Compositions Containing Anthraquinone Dyes  
A composition composition containing (A) an alkali-soluble binder and (B) an anthraquinone dye of formula (I) wherein R1, R2, R3 and R4 are each independently of the other hydrogen, Q-Cgalkyl...
US20090018356 Crystalline polymorph of exemestane  
New crystalline polymorph of exemestane characterized by a powder X-ray diffraction pattern having peaks at 10.7±0.1, 15.9±0.1, and 18.1±0.1 2-theta degree.
US20140221324 COMPOSITION FOR THE REDUCTION OF DRIP LOSSES IN PORK  
25-hydroxyvitamin D3 has been found to reduce drip losses in swine carcasses. Feed containing about 25-75 μg/kg 25-hydroxyvitamin D3 improves the water holding capacity of meats, including pork.
US20110166111 COMPOSITION FOR THE REDUCTION OF DRIP LOSSES IN PORK  
25-hydroxyvitamin D3 has been found to reduce drip losses in swine carcasses. Feed containing about 25-75 μg/kg 25-hydroxyvitamin D3 improves the water holding capacity of meats, including pork.
US20120149669 22-Haloacetoxy-Homopregnacalciferol Analogs and Their Uses  
This invention discloses 22-haloacetoxy-homopregnacalciferol analogs and specifically 22-bromoacetoxy-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits relatively...
US20130231316 Drug Combination Comprising a Selective Serotonin Reuptake Inhibitor and a Glucocorticoid Receptor Antagonist for the Treatment of Depression  
The invention provides for a combination comprising an amount of an SSRI, or a pharmaceutically acceptable salt or solvate thereof, and an amount of a GR antagonist, or a pharmaceutically...
US20140011973 COMPOUND WITH BRANCHING ALKYL CHAINS, METHOD FOR PREPARING THE SAME, AND USE THEREOF IN PHOTOELECTRIC DEVICE  
The invention discloses a compound having branching alkyl chains, the method for preparing the same and use thereof in photoelectric devices. By applying the branching alkyl chains as the...
US20070238704 2-Substituted-1Alpha,25-Dihydroxy-19,26,27-Trinor Vitamin D Analogs and Uses Thereof  
Compounds of formula I, II or III are provided where X1, X2 and X3 are independently selected from H and hydroxy protecting groups and R1 and R2 are independently selected from H or straight or...
US20130266645 DERIVATIVES OF STEROID BENZYLAMINES, HAVING AN ANTIPARASITIC ANTIBACTERIAL, ANTIMYCOTIC AND/OR ANTIVIRAL ACTION  
The present invention relates to compounds derived from steroids of the general formula (I) wherein L represents a linker and R# represents a steroid residue, the use of compounds of the general...
US20130012481 CRYSTALLINE FORMS OF TIGECYCLINE HYDROCHLORIDE  
The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of...
US20110105772 CRYSTALLINE FORMS OF TIGECYCLINE HYDROCHLORIDE  
The present invention relates to crystalline forms A and B of Tigecycline hydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of...
US20120046258 NOVEL CRYSTALLINE PHARMACEUTICAL PRODUCT  
There are provided crystalline particles of unsolvated Form 1 polymorph of the compound of formula (I): characterised in that the particles are in the form of substantially triangular plates.
US20080300228 Crystalline Rostafuroxin  
New crystalline forms of 17β-(3-Furyl)-5-βandrostane-3β,14β,17α-triol are described together with pharmaceutical composition containing the same and methods for their preparation. In particular...
US20050137380 Processes for preparing benzoquinones and hydroquinones  
A process for the preparation of benzoquinones and hydroquinones includes oxidizing an aromatic hydroxy compound with oxygen or an oxygen containing gas, a copper containing catalyst, and a...
US20060058241 Methods of treating disorders having a component of mercury toxicity  
The present invention relates to methods of lowering the level of mercury in a subject, methods of lowering the level of mercury in a child diagnosed with autism and methods of assessing the risk...
US20100226973 METHODS AND COMPOSITIONS FOR LIPOSOMAL FORMULATION OF ANTIGENS AND USES THEREOF  
The present invention relates to liposomal vaccine compositions, methods for the manufacture thereof, and methods for the use thereof to stimulate an immune response in an animal. These...
US20100074845 ENHANCED SENSITIVITY CARBON NANOTUBES AS TARGETED PHOTOACOUSTIC MOLECULAR IMAGING AGENTS  
The present disclosure provides contrast photoacoustic probes, and compositions comprising such probes, designed to non-invasively detect and monitor various disease states, or targets within a...
US20050256092 Antipsoriatic agent  
An object of the present invention is to synthesize a pharmaceutical effective for the treatment of psoriasis. A therapeutic agent for psoriasis, comprising...
US20050245496 High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one  
The invention pertains to a process for the preparation of a high-purity composition of (7α, 17α)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-on e. The process provides for a composition...
US20060079486 Lipopolymer conjugates  
Conjugates of formula I, below, are useful in biomedicinal applications such as delivery of drugs or labeling moieties or as components of liposomes or micelles. In formula I, A is a hydrophilic...
US20100240684 MINOXIDIL AQUEOUS COMPOSITION CONTAINING BILE ACID  
An object of the present invention is to provide a liquid composition wherein minoxidil can be dissolved at a relatively high concentration (the saturating amount or above), stimulation of skin...
US20100135956 STEROID MODULATORS OF PROGESTERONE RECEPTOR AND/OR GLUCOCORTICOID RECEPTOR  
The present invention relates to new steroid modulators of progesterone receptor activity and/or glucocorticoid receptor activity, pharmaceutical compositions thereof, and methods of use thereof.
US20090176754 Crystalline Form of the Compound A-348441  
There is provided a hemihydrate of (3β, 5β, 7α, 12α)-7,12-dihydroxy-3-{2-[{4-[17β-hydroxy-3-oxo-17α-prop-1-y nylestra-4,9-dien-11β-yl]phenyl}(methyl)amino]ethoxy}cholan- 24-oic acid in a...
US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs  
This invention discloses 2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro- 19-nor-vitamin D analogs, and specifically...
US20150141678 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY  
What is described is a compound of formula (1) wherein R1 and R2 are the same or different, each a linear or branched alkyl with 1-9 carbons, or an alkenyl or alkynyl with 2 to 11 carbon atoms;L1...
US20090253922 Process for Production of Steroid Compound  
The present invention relates to a process for production of a steroid compound having a partial structure represented by Formula (2) by oxidizing a steroid compound having a partial structure...
US20070238710 N-ARYL-N'ALKYL SULFAMIDES AS MEK INHIBITORS  
This invention concerns N-(ortho phenylaminoaryl), N′-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases.
US20070082876 Novel C18 modified retrosteroids as progesterone receptor modulator compounds  
Retrosteroidal compounds of formula I which act as progesterone receptor modulators, a method for their production, and pharmaceutical preparations containing these compounds. These compounds are...
US20100279850 CHEMICALLY-RESISTANT COATING COMPOSITION  
A coating composition comprising a Photocatalyst Composition comprising a photocatalyst and a pendent silyl ester group, wherein the photocatalyst produces singlet oxygen in the presence of light...
US20050032767 Method for obtaining a natural mixture of conjugated equine estrogens  
A method for obtaining an extract containing the natural mixture of conjugated equine estrogens in which a mixture of conjugated estrogens obtained by solid-phase extraction from pregnant mares'...
US20080090789 Tigecycline crystalline forms and processes for preparation thereof  
The present invention relates to solid crystalline Tigecycline, and crystalline forms thereof.
US20100009942 2-Methylene-(17Z)-17(20)-Dehydro-19,21-Dinor-Vitamin D Analogs  
This invention discloses 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs, and specifically 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-1α, 25-dihydroxyvitamin D3, and...
US20090029957 8-BETA-SUBSTITUTED ESTRATRIENES AS SELECTIVELY ACTIVE ESTROGENS  
The invention refers to 8β-substituted estra-1,3,5(10)-triene derivatives of general formula I their use as pharmaceutical active ingredients, which have in vitro a higher affinity to estrogen...
US20090068585 DISSOLUTION PROMOTER AND PHOTORESIST COMPOSITION INCLUDING THE SAME  
In the formation of a fine pattern using a photolithography process, a dissolution promoter which can increase the difference of solubility between exposed region and unexposed region, and a...
US20130203709 ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME  
The present disclosure relates to acylsulfonamides and processes for their preparation. The processes involve a target-guided synthesis approach, whereby a thioacid and a sulfonyl azide are...
US20140357608 TACCALONOLIDE MICROTUBULE STABILIZERS  
The invention provides epoxytaccalonolide microtubule stabilizers and their use as anti-proliferative microtubule stabilizing agents.
US20110306088 Mini-Reactor Optimized Channel Sizing  
A honeycomb body is disclosed having cells extending along a common direction, a first plurality of the cells being open at both ends of the body and a second plurality of the cells being closed...
US20110118228 Enzymatic production or chemical synthesis and uses for 5,7-dienes and UVB conversion products thereof  
Provided herein are steroidal compounds that are androsta-5,7-dienes or a pregna-5,7-dienes and ultraviolet B (UVB) conversion products thereof which includes pharmaceutical compositions of the...
US20100273759 PROGESTERONE ANTAGONISTS  
Described herein are compounds which exhibit progesterone antagonistic effects and methods of treating cancer using such compounds.